Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3377 of 6351
-
New hope for advanced liver cancer: first human trial of ABSK-011 begins
Disease control Recruiting nowThis is an open-label phase 1 study with an escalation part and an expansion part.
Phase 1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Cancer drug niraparib tested before prostate surgery – early trial stopped
Disease control Stopped earlyThis phase II trial studies how well niraparib, when given before surgery, works in treating patients with high risk prostate cancer that has not spread to other parts of the body (localized) and alterations in deoxyribonucleic acid (DNA) repair pathways. Niraparib may stop the g…
Phase 2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug cocktail targets Hard-to-Treat breast cancer mutation
Disease control CompletedThis is an open label, single arm, multicenter, phase Ib study to evaluate the safety and clinical activity of the combination of ipatasertib, trastuzumab and pertuzumab in patients with unresectable locally advanced or metastatic HER2-positive breast cancer with tumors harboring…
Phase 1 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New hope for aggressive brain tumors? early trial combines two targeted drugs
Disease control OngoingThis is a phase 1 study of atezolizumab in combination with D2C7-IT, a dual-specific monoclonal antibody (mAB) with a high affinity for both EGFRwt- and EGFRvIII-expressing cells, in patients with recurrent World Health Organization (WHO) grade IV malignant glioma at the Preston …
Phase 1 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Air purifiers may lower blood pressure in seniors near roadways
Disease control CompletedExposure to fine particulate matter (PM2.5) air pollution is an established risk factor for cardiovascular (CV) morbidity.
Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Experimental cancer combo trial halted early – what it means for patients
Disease control Stopped earlyA first-in-human study using BDC-1001 as a single agent and in combination with nivolumab in HER2 expressing advanced malignancies
Phase 1/2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:13 UTC
-
App aims to curb HIV crisis among young black men in alabama
Prevention CompletedThe overall goal of this 5-year Mentored Research Scientist Development K01-Award is to support Henna Budhwani, PhD, MPH to become an independent implementation science investigator in the field of HIV prevention. The proposed project seeks to address the HIV crisis in Alabama, w…
Sponsor: Florida State University • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC
-
Lifestyle overhaul may rewrite Sperm's epigenetic code
Knowledge-focused OngoingThis is a rigorous, controlled clinical trial designed to show that diet, exercise training, and their combination in overweight, inactive men will alter epigenetic programming to create a "healthy" sperm epigenome. Our central hypotheses are: i) overweight and inactive lifestyle…
Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Rowing with electric stimulation may ease pain after spinal cord injury
Symptom relief Stopped earlySpinal Cord Injury (SCI) leads to alterations in brain structure and function by spinal nerve damage, secondary inflammatory responses, and by the consequences of living with paralysis and neuropathic pain. Physical inactivity due to lower body paralysis rapidly leads to loss of …
Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Laughing gas may reveal brain clues for depression
Knowledge-focused CompletedRecent evidence suggest that Nitrous Oxyde (N2O) could exhibit antidepressant effect in treatment-resistant depression (TRD). However, the pathophysiology of this effect remains unclear and could include glutamatergic activity but also cerebrovascular effects and changes in brain…
Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Herbal blend shows promise against COVID-19 in small trial
Disease control CompletedAntiCov-220 prevents and treats before, during, and after infection with SARS-CoV-2. The composition is fractionally extracted from herbs (Ascorbic Acid, L-Arginine hydrochloride, Adenosma glutinosum extract, Eclipta prostrata extract, Phyllanthus urinaria extract, Impatiens bals…
Phase 4 • Sponsor: Nguyen Thi Trieu, MD • Aim: Disease control
Last updated Jun 26, 2026 16:25 UTC
-
Gene sleuths hunt for Antibiotic-Resistant bacteria in CF lungs
Knowledge-focused CompletedPulmonary exacerbations (PEx) are key events that lead to a decline in health status among CF patients, with many never recovering to baseline health. With the advancement of new CFTR modulators and other therapies increasing the lifespan of those living with CF, it will become i…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Zapping the brain to unlock words: new hope for Alzheimer's communication loss
Symptom relief CompletedImpaired verbal communication is a cardinal symptom of Alzheimer Disease (AD) and the source of enormous distress and disability. Effective therapies for this deficit are lacking. In light of the emerging literature demonstrating that Transcranial Magnetic Stimulation (TMS) impro…
Phase 1 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 26, 2026 17:06 UTC
-
New combo approach for MS: switching from natalizumab to cladribine
Disease control OngoingThe purpose of this study is to generate hypotheses regarding the safety, efficacy, and immunological impact of cladribine tablets after treatment with natalizumab in patients with relapsing-remitting multiple sclerosis (RRMS) and active secondary progressive multiple sclerosis (…
Phase 4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New needling technique could ease chronic pain without drugs
Symptom relief CompletedMarginalized populations are at increased risk of chronic pain, trauma and use of street drugs to manage this suffering, with the associated risk of overdoses. Non-pharmacological options to manage chronic pain are difficult for this population to access. myoActivation® is an inn…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 26, 2026 18:22 UTC
-
Stiff arteries after heart attack may signal future trouble
Knowledge-focused OngoingRisk assessment after myocardial infarction is critical in daily practice and evolution toward heart failure especially diastolic heart failure remains a key issue. All consecutive patients with myocardial infarction (either STEMI or NSTEMI but excluding type 2 MI) presenting at …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug duo takes on tough bladder cancer
Disease control OngoingThe purpose of this research study is to test the safety of avelumab and AVB-S6-500 and see what effects (good and bad) this combination treatment has on patients with advanced urothelial carcinoma.
Phase 1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Intensive therapy shows promise for kids with CP
Symptom relief CompletedThe aim of this study is to investigate the effects of a 2-week Neurodevelopmental Treatment (NDT)-based intensive physiotherapy program with active participation on postural control and selective motor control of the lower and upper extremities in children diagnosed with spastic…
Sponsor: Medipol University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Sleepio shows promise for Post-Stroke insomnia in small trial
Symptom relief CompletedThis study evaluates the efficacy of digital cognitive behavioural therapy for insomnia (Sleepio) in chronic stroke survivors. Half of the participants will receive access to the digital (online) programme, half will receive a leaflet with sleep hygiene information. The primary o…
Sponsor: University of Oxford • Aim: Symptom relief
Last updated Jun 26, 2026 15:53 UTC
-
Tiny heart implant aims to ease strain in rare lung disease
Disease control OngoingThe objectives of the RELIEVE-PAH study are to obtain first-in-human experience with the study device in patients with severe pulmonary arterial hypertension, including evidence of initial safety, device performance and possible signals of clinical effectiveness.
Sponsor: V-Wave Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC